Alle Storys
Folgen
Keine Story von Dr. Hönle AG mehr verpassen.

Dr. Hönle AG

EANS-News: Hönle returns to the Profit Zone

Gräfeling/München (euro adhoc) -

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
quarterly report
Hönle Group returned to the profit
zone in the first quarter of the 2009/2010 financial year. The 
operating result (EBIT) increased from TEUR -592 in the previous year
to TEUR 1,229 in the first quarter of the current financial year, 
while sales revenues were down 3% to TEUR 12,372, year-on-year. The 
pretax result jumped from TEUR -594 to TEUR 1,168 and the 
consolidated result from TEUR -580 to TEUR 821. Earnings per share 
climbed from EUR -0.12 to EUR 0.15.
The operating cash flow improved from TEUR -676 in the previous year 
to TEUR 312 in the first quarter of the current financial year.
Outlook: Due to the acquisition of Eltosch, Panacol and PrintConcept,
the Hönle Group became the second largest systems supplier worldwide 
for industrial UV technology. Following the restructuring process in 
2008/2009, the Group has greatly expanded its sales and earnings 
potential and lowered its break-even threshold significantly. The 
Group has thus laid the basis for sustained positive business 
development. Hence, Hönle is excellently prepared to emerge from the 
economic and financial crisis in a stronger position than previously.
Presently, there are many signs of the global economy gradually 
overcoming the effects of the global recession. The Ifo Business 
Climate Index in Germany is increasing considerably and institutions 
such as the International Monetary Fund forecast a global recovery 
for 2010.
The Hönle Group is also experiencing a rebound in demand with respect
to some business segments, and stabilisation at a low level in 
others. A slight recovery at a still low sales level can be noted in 
the sheet-fed offset printing segment. Hönle expects this segment to 
pick up further in the future. Incoming orders increased 
significantly in other print application segments such as the digital
printing segment, when compared to previous quarters. Hönle expects 
the recovery trend to continue in this segment also. Incoming orders 
picked up continuously in the adhesives segment. Positive business 
development can be noted in South-East Asia, in particular. Hönle has
good opportunities to tap new sales potential in that area. The 
positive business development that prevailed even during the 
recession continues unabated in the special equipment segment: The 
photovoltaics industry is the growth driver in this segment.
Provided that the general economic conditions do not deteriorate, the
Management Board expects that the Hönle Group will achieve sales 
revenues ranging from EUR 47 to EUR 50 million, while the operating 
result is expected to come in at EUR 3 to EUR 4 million in the 
current financial year.
About Hönle: Dr. Hönle AG is a listed technology company with 
registered head office in Gräfelfing, near Munich. With a staff level
of ca. 250 employees, the Hönle Group is one of the world´s leading 
systems suppliers in the UV technology segment. The equipment and 
systems are used for drying inks and coatings, curing adhesives and 
plastics, disinfecting surfaces, and in the simulation of natural 
sunlight. The Company´s business activities focus also on the 
development and sale of industrial adhesives and compounds. The Group
is represented by own companies and sales partners worldwide at 50 
locations in more than 20 countries.
end of announcement                               euro adhoc

Further inquiry note:

Peter Weinert
Tel.: +49 89 85608 173
E-Mail: peter.weinert@hoenle.de

Branche: Instrument Engineering
ISIN: DE0005157101
WKN: 515710
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Weitere Storys: Dr. Hönle AG
Weitere Storys: Dr. Hönle AG